Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Transatlantic Network of Excellence for the Identification of Novel Genetic Targets in Hemorrhagic Stroke

European Coordinator:
  • Elisabetta DEJANA, Institute of Molecular Oncology Foundation, Milan (Italy)
North American Coordinator:
  • Brant Michael WEINSTEIN, NIH/LMG, Bethesda (USA)
Members:
  • Christer BETSHOLTZ, Karolinska Institutet, Stockholm (Sweden)
  • Ulf ERIKSSON, Karolinska Institutet, Stockholm (Sweden)
  • Louis F. REICHARDT, University of California, San Francisco (USA)
  • Elisabeth TOURNIER-LASSERVE, UFR Lariboisière Saint-Louis, Paris (France)

Intracerebral hemorrhage (ICH), bleeding into the brain matter, is a particularly severe form of stroke that often leads to disability or death.  It remains difficult to prevent and to treat. Although hypertension and other factors may play a role in the onset of ICH, in many cases no specific cause can be identified.  Members of this network have independently shown that genetic susceptibility plays a role in some forms of ICH. Now, working together, the members of this network continue the systematic search for the genetic basis of ICH. The collaborative effort, among leaders in the field who have complementary areas of expertise, uses animal models, as well as samples from ICH patients, to investigate genes that control blood vessel function and maintenance in the brain. The ultimate objectives of network are to develop a diagnostic test for predisposition to ICH which might allow for preventive measures and effective treatment.